Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 274Breast Neoplasms 263Lung Neoplasms 135Prostatic Neoplasms 115Colorectal Neoplasms 107Carcinoma, Non-Small-Cell Lung 103Pancreatic Neoplasms 70Carcinoma, Hepatocellular 55Ovarian Neoplasms 51Multiple Myeloma 50Hematologic Neoplasms 50Urinary Bladder Neoplasms 49Stomach Neoplasms 49Brain Neoplasms 48Melanoma 44Leukemia, Myeloid, Acute 43Head and Neck Neoplasms 43Esophageal Neoplasms 41Disease 38Rectal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Liver Neoplasms 36Colonic Neoplasms 35Lymphoma 34Neoplasm Metastasis 33Leukemia, Lymphocytic, Chronic, B-Cell 31Endometrial Neoplasms 30Kidney Neoplasms 29Carcinoma, Renal Cell 29Recurrence 28

Interventions

Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Postural Orthostatic Tachycardia Syndrome × 90 days × Clear all
NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡